Julie Morse's Blog – June 2018 Archive (10)

Children with autism are at a greater risk for developing skin allergies, according to a recent study published in JAMA Network Open. The findings could potentially help behavioral researchers better understand mood swings and anxiety exhibited in young people…

Dermatology has a diversity problem, and according to dermatologists at the University of California San Francisco, the root of this racial imbalance begins with residency admissions.

Only …

Humans are typically happier in the summer. Sunlight increases our serotonin levels, thus regulating our mood and making us feel more relaxed. As enjoyable as it is to spend time outdoors in the warmer months, there are some summer-related skin conditions you should be aware of:

Plant rashes…

A hair salon in New Orleans is teaching stylists to identify skin cancer on their clients’ scalps as a way to help increase the rate of early melanoma detection.

Mark the SPOT! is…

Pharmacy aisles are brimming with products that claim to cure all kind of skin ailments. However, studies show that the key to good skin isn’t a quick-fix serum or cream but maintaining a healthy gut. The …

In many specialties, it seems that artificial intelligence (AI) is gaining a lead on human physicians. Dermatology is the latest field to reckon with the technology, as a new international study…

Is your state giving you skin cancer? A recently released study from the Blue Cross Blue Shield Association (BCBSA) analyzed the rates of skin cancer…

A new study published in JAMA Dermatology has found that despite rates of melanoma diagnoses increasing among non-Latino white-skinned people over the age of 45 and younger than 15, there has been a significant drop in melanoma incidence among people…

Physician assistants have significantly contributed to patient health services by reducing long dermatology appointment wait times and lowering clinical costs. However, according to a recent study conducted by University of Pittsburgh School of Medicine research, physician assistants have a less accurate melanoma diagnosis rate than…

Verrica Pharmaceuticals has filed for an initial public offering to raise $86.25 million for VP-102, a cantharadin-based topical treatment for molluscum contagiosum and Verruca Vulgaris (plantar warts). This is Verrica’s lead product.  

“Our lead product candidate, VP-102, is a proprietary…